IVD Import License India: Classification, Form MD-14 Process & Complete 2026 Guide for Diagnostic Device Importers

• In-Vitro Diagnostic Devices (IVDs) follow a separate, dedicated classification track under MDR 2017 — distinct from general medical devices — with Class A through D based on risk and intended use.
• Every IVD importer in India must apply for an import license using Form MD-14, but IVDs require additional product-specific documents like performance evaluation data, clinical sensitivity/specificity reports, and reference material details.
• The Form MD-14 process for IVDs differs from general medical devices in its documentation depth, testing requirements, and the regulatory scrutiny applied — especially for HIV, hepatitis, and blood screening kits (Class D IVDs).
• As of 2026, all four classes of IVDs are under mandatory licensing — skipping or delaying the process can result in customs holds, financial penalties, and reputational damage with Indian hospital and laboratory buyers.

Introduction

If you are an importer of In-Vitro Diagnostic Devices — ranging from blood glucose meters and pregnancy test kits to PCR diagnostics and HIV screening assays — you already know that India is one of the fastest-growing diagnostic markets in the world. But with that growth comes a very structured regulatory environment that you cannot afford to navigate casually.

Most importers are broadly aware of the CDSCO import license process under Form MD-14. What many do not realize, however, is that IVDs are not simply lumped into the general medical device category. They have their own dedicated classification system, their own risk parameters, and their own set of documentation requirements that differ in meaningful ways from non-IVD medical devices.

This guide is specifically designed for importers, regulatory affairs professionals, and authorized Indian agents dealing with IVD import license India requirements in 2026. We cover everything from the ground up — what IVDs are, how they are classified under MDR 2017, what Form MD-14 requires specifically for IVDs, and how the process differs from importing general medical devices.

Whether you are bringing in rapid antigen test kits, clinical chemistry analyzers, molecular diagnostic systems, or point-of-care devices, this guide gives you a clear and accurate picture of what the Indian regulatory framework demands.

What Are In-Vitro Diagnostic Devices (IVDs)?

In-Vitro Diagnostic Devices (IVDs) are medical devices — reagents, kits, instruments, systems, or software — intended to examine specimens derived from the human body for the purpose of diagnosis, monitoring, treatment decisions, or screening of disease.

The phrase 'in-vitro' literally means 'in glass' — referring to tests performed outside the body, on samples like blood, urine, saliva, tissue, or other biological fluids. This is what distinguishes IVDs from implants or surgical instruments.

IVDs touch almost every branch of healthcare — from primary health centers using simple rapid tests to tertiary hospitals running high-throughput automated analyzers. That breadth, combined with the direct impact these devices have on patient diagnosis and treatment, is precisely why India's MDR 2017 gives them their own classification framework.

Regulatory Framework for IVDs in India

IVDs were officially brought under the Medical Devices Rules, 2017 (MDR 2017) — notified under the Drugs and Cosmetics Act, 1940. Before MDR 2017, only a limited list of IVDs (like HIV and Hepatitis kits) were regulated. The 2017 rules expanded coverage significantly, and subsequent notifications in 2020 and 2022 brought additional IVD categories into the fold.

IVD Classification Under MDR 2017: Class A Through D

This is where IVDs diverge from general medical devices. MDR 2017 uses Schedule II-C to classify IVDs into four risk-based classes. Unlike the classification of general devices, IVD classification is driven by factors like the consequences of incorrect results, the intended user (professional vs. self-test), the analyte being detected, and whether the device is used for life-threatening disease screening.

IVD Class A — Low Individual Risk, Low Public Health Risk

These are general-purpose laboratory instruments and reagents that pose low individual and public health risk. Errors in results have limited direct clinical impact.

IVD Class B — Low Individual Risk, Moderate Public Health Risk

These IVDs have a moderate potential for public health impact, often because they detect conditions that — if missed — could lead to wider community spread or delayed treatment.

IVD Class C — High Individual Risk, Moderate-High Public Health Risk

These are diagnostics for serious conditions where a wrong result — false negative or false positive — can have significant clinical consequences for the individual patient.

IVD Class D — Highest Individual and Public Health Risk

Class D IVDs represent the most critical category. These are devices used to screen blood for transfusion-transmitted infections, detect life-threatening diseases where a missed diagnosis has irreversible consequences, or where the disease has high epidemic potential. CDSCO applies the strictest regulatory scrutiny to this class.

How IVD Classification Differs from General Medical Device Classification

This is a point of confusion for many regulatory professionals, especially those transitioning from general medical device work into IVD regulation. The classification logic is fundamentally different:

Form MD-14 for IVD Import: How It Works

All IVD importers in India must submit Form MD-14 to CDSCO to obtain the import license (issued in Form MD-15). The basic framework is the same as for general medical devices — you apply via the SUGAM portal, pay the applicable fee, and await CDSCO review. But what goes inside the application is where IVDs diverge significantly.

The depth of documentation, the performance data requirements, and the specific technical standards that apply to IVDs make their Form MD-14 dossier considerably more complex than a typical general medical device application. Let us walk through it step by step.

Step-by-Step Form MD-14 Process for IVD Importers

Documents Required for Form MD-14: IVD-Specific Requirements

IVD applications share some common documents with general medical devices, but also require a distinct set of IVD-specific technical and clinical documents. Here is a comprehensive breakdown:

Section A: Standard Documents (Common with General Medical Devices)

Section B: IVD-Specific Technical Documents

Section C: Market Authorization Documents

Form MD-14 for IVDs vs General Medical Devices: Key Differences

This is the section most importers need most urgently. If you have previously handled Form MD-14 for general medical devices and are now moving into IVDs, here is a precise comparison of where the two tracks diverge:

Eligibility Criteria for IVD Import License via Form MD-14

The eligibility requirements for IVD import mirror the general Form MD-14 criteria, but with some additional layers specific to diagnostics:

For the Foreign IVD Manufacturer

• Must be a legally registered manufacturer in the country of origin.
• ISO 13485 certification is expected; for Class D IVDs, compliance with ISO 15189 (medical laboratory quality) principles in manufacturing is an advantage.
• Must have existing market authorization (CE-IVD, FDA clearance, or equivalent) — especially for Class C and D IVDs.
• Must authorize an Indian agent in writing, with specific mention of the IVD products and scope of authorization.
• Must be prepared for manufacturing site inspection for Class C and D IVDs — CDSCO or its authorized inspection bodies may conduct on-site or remote audits.

For the Authorized Indian Agent / Importer

• Must be a registered Indian entity — company, LLP, or individual with valid legal status.
• Must hold a valid Drug License / Medical Device License from the State Licensing Authority for the import and storage premises.
• Storage premises must meet temperature and environmental conditions required for IVDs — particularly for cold-chain products (2°C–8°C or -20°C storage).
• Must appoint a Technically Qualified Person (TQP) — typically a pharmacy graduate, medical graduate, or life sciences graduate with relevant experience.
• Must have cold chain infrastructure documented if the IVD requires refrigerated or frozen storage and transport.
• Must be capable of maintaining post-market surveillance records and filing adverse event reports as required for the IVD class.

Government Fees for IVD Import License (Form MD-14) — 2026

The fee structure for IVD import license applications follows the same Schedule VII of MDR 2017 that applies to general medical devices. However, fees are applied per device/product application, and IVDs — especially Class C and D — often involve multiple products, making total cost a significant planning factor.

Validity and Renewal of IVD Import License

The import license for IVDs (issued in Form MD-15) is valid for 3 years from the date of grant — same as general medical devices. However, IVD-specific renewal considerations make early action even more important.

Post-Approval Compliance for IVD Importers

Holding a valid IVD import license is not a one-time achievement. Indian regulations — and global best practice — require ongoing compliance that active importers must manage systematically:

• Batch Release Records: Every imported batch of IVDs must have complete documentation — lot number, manufacturing date, expiry date, quantity imported, and certificate of analysis from the manufacturer.
• Quality Control Testing at Importation: For Class D IVDs, CDSCO may require testing of imported batches at government-approved laboratories before distribution — do not plan to sell immediately upon arrival.
• Adverse Event Reporting: If a distributed IVD causes or is suspected to have contributed to an incorrect diagnosis leading to patient harm, this must be reported to CDSCO within prescribed timelines.
• Field Safety Corrective Actions (FSCA): Any recall, market withdrawal, or field safety notice issued by the manufacturer globally must be mirrored with appropriate action in India and reported to CDSCO.
• Labeling Compliance: Every IVD pack must carry Indian-market labeling compliant with MDR 2017 Schedule IV — including instructions in English (and Hindi where required), storage conditions, lot number, and importer details.
• Cold Chain Documentation: For temperature-sensitive IVDs, maintain temperature records throughout the storage and distribution chain. Breaks in cold chain must be documented and products evaluated before further distribution.
• Annual Returns: Depending on licensing conditions, annual returns detailing import quantities, sales data, and adverse event summary may need to be filed with CDSCO.
• License Amendment for Changes: Changes to product design, labeling, manufacturing site, storage conditions, or importer details require a license amendment before implementation.

Special IVD Categories with Additional Regulatory Requirements

Some IVDs go beyond the standard Form MD-14 framework due to their specific nature, intended use, or public health significance:

1. HIV and Blood Screening IVDs

HIV and blood-screening IVDs are Class D and among the most tightly regulated. In addition to the standard Form MD-14 dossier, CDSCO has historically required:

• Prior approval under specific government notification for HIV diagnostic kits.
• Performance evaluation against Indian epidemiology — the device must detect the HIV strains prevalent in the Indian population.
• In some cases, approval from the National AIDS Control Organization (NACO) technical committee in addition to CDSCO clearance.

2. Point-of-Care (POC) and Self-Test IVDs

POC diagnostics and self-test IVDs — like home glucose monitors, home pregnancy tests, and OTC rapid tests — fall under Class C or higher and require additional documentation:

• Usability studies demonstrating that lay users (not laboratory professionals) can operate the device correctly without errors.
• Labeling specifically designed for non-expert users — with warnings, failure mode messaging, and referral recommendations.
• Performance data under conditions of actual home use (environmental variation, user error tolerance).

3. Companion Diagnostics (CDx)

A Companion Diagnostic is an IVD used to identify patients likely to benefit from (or at risk from) a specific therapeutic. CDSCO has been aligning with global CDx frameworks and the requirements include:

• Formal CDx designation and co-development relationship with the linked therapeutic device or drug.
• Clinical validation data specifically generated in the context of the linked treatment decision.
• Coordination between the CDx import application and the corresponding drug or biologic regulatory pathway in India.

4. Nucleic Acid Testing (NAT) and Molecular Diagnostics

PCR kits, RT-PCR systems, and other NAT-based diagnostics — especially those used for blood bank screening or infectious disease panels — face additional requirements:

• Detailed validation data covering sensitivity of detection (limits of detection), specificity across genotypes, and cross-reactivity panel testing.
• Instrument-reagent system compatibility documentation if the kit is designed for a specific platform.
• Labeling requirements specific to NAT systems, including contamination prevention warnings.

Common Mistakes IVD Importers Make in the Form MD-14 Process

Learning from others' experience can save months of delay. These are the most frequently seen issues in IVD import license applications:

• Wrong IVD Classification: Classifying under the general medical device schedule instead of Schedule II-C, or classifying at a lower risk class than warranted — CDSCO will flag this and may return the application.
• Missing Performance Evaluation Data: Submitting a dossier with only CE or FDA approval certificates but without standalone performance evaluation reports — approval certificates are supporting documents, not substitutes for performance data.
• Outdated Clinical Data: Submitting clinical validation data that is more than 5 years old without a contemporaneous performance update — CDSCO may question the current relevance of the data.
• No Third-Party Lab Report for Class D: Attempting to submit a Class D IVD application without the independent performance test report from a CDSCO-approved laboratory — this is a non-starter.
• Inadequate Indian Labeling: Draft Indian labels that do not include all Schedule IV mandatory elements, or that are direct translations of English labels without proper localization for the Indian market.
• Cold Chain Gap in Premises: Declaring storage premises for refrigerated or frozen IVDs without verified cold chain infrastructure documentation — CDSCO inspectors and state licensing authorities check this.
• Failing to Differentiate Reagent Kits from Instruments: Treating an analyzer system and its consumable reagent kits as a single product in the application — they often require separate applications.

SUGAM Portal: Practical Guide for IVD Importers

Conclusion: Getting Your IVD Import Strategy Right for 2026

India's IVD import license framework under MDR 2017 is thorough, and for good reason. Diagnostic devices directly influence clinical decisions. A missed HIV diagnosis from a substandard test kit or an incorrect blood glucose reading in a diabetic patient can have serious, sometimes irreversible consequences. The regulatory framework exists to prevent exactly this.

For importers, the key takeaway is this: IVDs are not a sub-category of general medical devices — they are a parallel track with their own classification logic, their own documentation depth, and their own performance verification standards. Treating an IVD import application like a routine medical device application is the fastest path to rejection.

Whether you are importing rapid antigen kits, high-throughput clinical chemistry systems, or life-saving blood screening assays, approaching the Form MD-14 IVD import process with the right preparation — complete documentation, correctly classified devices, verified cold chain infrastructure, and realistic timelines — is what separates importers who grow in the Indian market from those stuck in regulatory limbo.

Start early, classify correctly, build a complete dossier, and partner with regulatory experts who understand both the technical and procedural nuances of CDSCO's IVD licensing framework. That is the surest way to secure your import license and build a sustainable diagnostics business in India.

Frequently Asked Questions